He is also a member of the Tumor Immunology & Immunotherapy program in the Greenebaum Cancer Center at the University of Maryland Medical Center. Greg’s research focuses on using engineering approaches to 1) direct the immune system using engineered therapies and 2) determine how networks of cells function to produce immune responses or dysfunction in diseases.